Hiroki Izumi1, Taofeek K. Owonikoko2, Stephane Champiat3, Melissa Johnson4, Ramaswamy Govindan5, Victoria Lai6, Hossein Borghaei7, Michael Boyer8, Rene J. Boosman9, Horst-Dieter Hummel10, Fiona H. Blackhall11, Noemi Reguart12, Afshin Dowlati13, Yiran Zhang14, Sujoy Mukherjee14, Mukul Minocha14, Yanchen Zhou15, Aditya Shetty14, Nooshin Hashemi Sadraei14, Luis Paz-Ares Rodrigues16
1Department of Thoracic Oncology, National Cancer Center Hospital East, 2Department of Hematology and Medical Oncology, Emory University School of Medicine, 3Drug Development Department (DITEP) Gustave Roussy, Paris-Saclay University, 4Lung Cancer Research, Sarah Cannon Research Institute, Tennessee Oncology, 5Divisions of Hematology and Oncology, Washington University Medical School, 6Thoracic Oncology Service, Department of Medicine, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, 7Department of Hematology / Oncology, Fox Chase Cancer Center, 8Chris O'Brien Lifehouse, 9The Netherlands Cancer Institute, 10Translational Oncology / Early Clinical Trial Unit (ECTU), Comprehensive Cancer Center Mainfranken, University Hospital Wuerzburg, 11Department of Medical Oncology, The Christie NHS Foundation Trust, Division of Cancer Sciences, University of Manchester, 12Department of Medical Oncology, Hospital Barcelona, 13Division of Hematology and Oncology, Department of Medicine, University Hospitals Seidman Cancer Center and Case Western Reserve University, 14Amgen Inc., Thousand Oaks, 15Amgen Inc., South San Francisco, 16Hospital Universitario 12 de Octubre, H 120H120-CNIO Lung Cancer Clinical Research Unit, Universidad Complutense & Ciberonc
Japanese Journal of Lung Cancer 61(6): 549-549, 2021.